Bio Preventive Medicine Corp.
6810StockTWO
27.40 ▲ +0.37%
12 juin 2026
6
Bio Preventive Medicine Corp.
27.40 ▲ +0.37%
12 juin 2026
6810StockTWO

01 / À propos

Bio Preventive Medicine Corp., a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It also provides DNlite test, a series of patented and clinically validated non-invasive urine test for monitoring the progression of diabetic nephropathy, including DNlite-IVD103 and DNlite-DN_Score. Bio Preventive Medicine Corp. was founded in 2014 and is headquartered in Zhubei, Taiwan.

Arberion
Loading market data